BioCentury
ARTICLE | Company News

Cytokinetics, GlaxoSmithKline deal

December 14, 2009 8:00 AM UTC

Cytokinetics and GlaxoSmithKline agreed to terminate a 2001 cancer deal, including returning rights to the biotech for GSK-923295. GSK will complete an ongoing Phase I trial of the small molecule cen...